Inspire Medical Systems develops implantable therapeutic devices for the treatment of obstructive sleep apnea.
Inspire Medical Systems is a developer of innovative, implantable neurostimulation technologies to treat Obstructive Sleep Apnea (OSA). Utilizing well-established technologies from the fields of cardiac pacing and neurostimulation, Inspire has developed a proprietary Upper Airway Stimulation (UAS) therapy for patients who suffer from OSA.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 18, 2016 | Series F | $38M | 1 | — | — | Detail |
May 15, 2014 | Series E | $40M | 2 | — | — | Detail |
May 11, 2012 | Series C | $14.50M | 2 | Medtronic | — | Detail |
Jun 29, 2009 | Series B | $17M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Medtronic | — | Series F |
GDN Holdings | — | Series E |